CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-20 | Jones William Benton See Remarks | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2024-12-20 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2024-12-20 | MILLER RICHARD A MD President and CEO | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2024-06-13 | Grais Linda Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-13 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-13 | Morrison Scott W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-13 | Gould Terry P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-06-13 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-10 | MILLER RICHARD A MD President and CEO | Gift | −302,016 | 1,188,103 | ||
| 2024-05-06 | Thompson Peter A. Director | Purchase · Pre-Funded Warrants (right to buy) | +1,444,085 | $1.73 | $2.5M | 1,444,085 |
| 2024-05-06 | Thompson Peter A. Director | Purchase · Common Warrants (right to buy) | +1,397,684 | 1,397,684 | ||
| 2024-05-06 | ORBIMED ADVISORS LLC Director | Purchase · Pre-Funded Warrants (right to buy) | +1,444,085 | $1.73 | $2.5M | 1,444,085 |
| 2024-05-06 | ORBIMED ADVISORS LLC Director | Purchase · Common Warrants (right to buy) | +1,397,684 | 1,397,684 | ||
| 2024-05-06 | Jones William Benton See Remarks | Purchase | +20,000 | $1.73 | $35K | 153,773 |
| 2024-05-06 | Jones William Benton See Remarks | Purchase · Warrant (Right to Buy) | +19,357 | 19,357 | ||
| 2024-05-06 | MILLER RICHARD A MD President and CEO | Purchase | +577,634 | $1.73 | $1000K | 577,634 |
| 2024-05-06 | MILLER RICHARD A MD President and CEO | Purchase · Warrant (Right to Buy) | +559,073 | 559,073 | ||
| 2024-02-28 | Arcara Jeffrey Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2023-12-06 | MILLER RICHARD A MD President and CEO | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2023-12-06 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 |
Page 4 of 15 · 286 trades